Do you monitor CBCs to assess for drug toxicity in patients on nintedanib?

Not typically. I've never been advised to check these, but it's worth re-examining whether it's worthwhile. Looking at the side effect profile in INBUILD and INPULSIS doesn't reveal any major cytopenias. It doesn't appear to be on the FDA prescription information, either.

I think this question arise...